Related Experiment Video

Updated: Jan 15, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K

The crosstalk of m6A modification and non-coding RNAs in ferroptosis regulation in human diseases

Ying Zhu1, Meihuan Chen2, Xinyuan Feng1

  • 1Medical Genetic Diagnosis and Therapy Center of Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laboratory of Prenatal Diagnosis and Birth Defect, Fuzhou 350001, China; Key Laboratory of Clinical Laboratory Technology for Precision Medicine (Fujian Medical University), Fujian Province University, Fuzhou, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|October 10, 2025
PubMed

Insights

N6-methyladenosine (m6A) modification and non-coding RNAs (ncRNAs) interact to regulate ferroptosis, a cell death pathway implicated in diseases. Understanding this crosstalk offers therapeutic potential for ferroptosis-linked conditions.

Area of Science:

  • Epitranscriptomics
  • Molecular Biology
  • Cellular Biology

Background:

  • N6-methyladenosine (m6A) is a crucial epitranscriptional modification regulating RNA metabolism.
  • Non-coding RNAs (ncRNAs) are key players in gene regulation and interact with m6A.
  • Ferroptosis, an iron-dependent cell death, is linked to metabolic diseases, neurological disorders, and cancer.

Purpose of the Study:

  • To review the intricate crosstalk between m6A modification and ncRNAs.
  • To elucidate the mechanisms by which this interaction regulates ferroptosis.
  • To highlight the implications for therapeutic strategies in ferroptosis-associated diseases.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of regulatory mechanisms at the RNA and protein levels.
  • Examination of the role of m6A-ncRNA interplay in ferroptosis.

Main Results:

  • m6A modification influences ncRNA expression, and ncRNAs modulate m6A regulators.
  • This bidirectional regulation impacts ferroptosis pathways.
  • The m6A-ncRNA axis plays a significant role in various pathological conditions.

Conclusions:

  • The interplay between m6A and ncRNAs is a critical determinant of ferroptosis.
  • Targeting this regulatory axis presents a promising avenue for treating ferroptosis-related diseases.
  • Further research is needed to fully harness this axis for therapeutic benefit.
Keywords:
CrosstalkFerroptosisM6A modificationNcRNAsTherapeutic strategies

Related Concept Videos

Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
17.5K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.7K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K